scholarly journals Association between CCR5-Δ32 homozygosity and mortality in 37,650 participants from three U.S.-based cohorts

2019 ◽  
Author(s):  
Xia Jiang ◽  
Hongyan Huang ◽  
Francine Grodstein ◽  
Peter Kraft

An analysis of 409,693 UK Biobank participants recently published in Nature Medicine identified a relative 21% increase in all-cause mortality among participants who were homozygous for the Δ32 deletion in the C-C motif chemokine receptor 5 gene (CCR5).1 This is a timely and potentially cautionary result in light of He Jiankui’s controversial germline editing of CCR5 to induce mutations that putatively mimic the effects of Δ32, which is known to reduce the risk of HIV infection. To provide additional evidence on the association between the Δ32 deletion and mortality and assess its generalizability, we present results from three large-scale population-based US cohorts: the Nurses’ Health Study (NHS),2 the NHSII and the Health Professional Follow-Up Study (HPFS).3

Author(s):  
David J. Cote ◽  
Stephanie A. Smith-Warner ◽  
Jordan H. Creed ◽  
Jeremy Furtado ◽  
Travis Gerke ◽  
...  

2007 ◽  
Vol 165 (9) ◽  
pp. 1039-1046 ◽  
Author(s):  
T. Marugame ◽  
S. Yamamoto ◽  
I. Yoshimi ◽  
T. Sobue ◽  
M. Inoue ◽  
...  

2020 ◽  
Vol 109 (11) ◽  
pp. 1352-1357 ◽  
Author(s):  
Benedikt Schrage ◽  
Nicole Rübsamen ◽  
Andreas Schulz ◽  
Thomas Münzel ◽  
Norbert Pfeiffer ◽  
...  

Abstract Background Iron deficiency is now accepted as an independent entity beyond anemia. Recently, a new functional definition of iron deficiency was proposed and proved strong efficacy in randomized cardiovascular clinical trials of intravenous iron supplementation. Here, we characterize the impact of iron deficiency on all-cause mortality in the non-anemic general population based on two distinct definitions. Methods The Gutenberg Health Study is a population-based, prospective, single-center cohort study. The 5000 individuals between 35 and 74 years underwent baseline and a planned follow-up visit at year 5. Tested definitions of iron deficiency were (1) functional iron deficiency—ferritin levels below 100 µg/l, or ferritin levels between 100 and 299 µg/l and transferrin saturation below 20%, and (2) absolute iron deficiency—ferritin below 30 µg/l. Results At baseline, a total of 54.5% of participants showed functional iron deficiency at a mean hemoglobin of 14.3 g/dl; while, the rate of absolute iron deficiency was 11.8%, at a mean hemoglobin level of 13.4 g/dl. At year 5, proportion of newly diagnosed subjects was 18.5% and 4.8%, respectively. Rate of all-cause mortality was 7.2% (n = 361); while, median follow-up was 10.1 years. After adjustment for hemoglobin and major cardiovascular risk factors, the hazard ratio with 95% confidence interval of the association of iron deficiency with mortality was 1.3 (1.0–1.6; p = 0.023) for the functional definition, and 1.9 (1.3–2.8; p = 0.002) for absolute iron deficiency. Conclusions Iron deficiency is very common in the apparently healthy general population and independently associated with all-cause mortality in the mid to long term. Graphic abstract


2006 ◽  
Vol 118 (9) ◽  
pp. 2315-2321 ◽  
Author(s):  
Kyung-Jae Lee ◽  
Manami Inoue ◽  
Tetsuya Otani ◽  
Motoki Iwasaki ◽  
Shizuka Sasazuki ◽  
...  

2019 ◽  
Author(s):  
Knut Hagen ◽  
Lars Jacob Stovner ◽  
Kristian Bernhard Nilsen ◽  
Bendik Slagsvold Winsvold

Abstract Background Increased high sensitivity C- reactive protein (hs-CRP) levels have been found in many earlier studies on migraine, and recently also in persons with migraine and insomnia. The aim of this study was to see whether these findings could be reproduced in a large-scale population-based study. Methods A total of 50,807 (54%) out of 94,194 invited aged ≥ 20 years or older participated in the third wave of the Nord-Trøndelag Health Study study performed in 2006-2008. Among these, 38,807 (41%) had valid measures of hs-CRP and answered questions on headache and insomnia. Elevated hs-CRP was defined as >3.0 mg/L. The cross-sectional association with headache was estimated by multivariate analyses using multiple logistic regression. The precision of the odds ratio (OR) was assessed with 95% confidence interval (CI). Results In the fully adjusted model, elevated hs-CRP was associated with migraine (OR 1.14, 95% CI 1.04-1.25) and migraine with aura (OR 1.15, 95% CI 1.03-1.29). The association was stronger among individuals with headache ≥ 7 days/month for any headache (OR 1.19, 95% CI 1.08-1.31), migraine (OR 1.30, 95% CI 1.10-1.54), migraine with aura (OR 1.47, 95% CI 1.20-1.80), and other headaches (OR 1.16, 95% CI 1.03-1.30). No clear relationship was found between elevated hs-CRP and headache less than 7 days/month or with insomnia. Conclusions Cross-sectional data from a large-scale population-based study showed that elevated hs-CRP was associated with headache ≥ 7 days/month, especially frequent migraine with aura.


2020 ◽  
Author(s):  
Trine Moholdt ◽  
Clifford Afoakwah ◽  
Paul Scuffham ◽  
Christine McDonald ◽  
Louise Burrell ◽  
...  

Abstract BackgroundAlthough it is known that winter inclusive of the Christams holiday period is associated with an increased risk of dying compared to other times of the year, very few studies have specifically examined this phenomenon within a population cohort subject to baseline profiling and prospective follow-up. In such a cohort, we sought to determine the specific characteristics of mortality occuring during the Christmas holidays. MethodsBaseline profiling and outcome data were derived from a prospective population-based cohort with longitudinal follow-up in Central Norway - the Nord-Trøndelag Health Study. From 1984-1986, 88% of the target population comprising 39,273 men and 40,353 women aged 48±18 and 50±18 years, respectively, were profiled. We examined the long-term pattern of all-cause mortality and specific causes of death according to season, month and individual days of the year to determine the number of excess (cause-specific) deaths occuring at key timepoints (including the Christmas holidays). ResultsDuring 33.5 (IQR 17.1-34.4) years follow-up, 19,879 (50.7%) men and 19,316 (49.3%) women died at age-adjusted rate of 5.3 and 4.6 deaths per 1000/annum, respectively. Each winter, there were 44 (95% CI 43-45) more all-cause deaths compared to summer, with 21 (95% CI 20-22) more deaths attributable to cardiovascular disease. Compared to any other time of the year, December 25th-27th was the deadliest; being associated with an excess of 1.3 (95% CI 1.1-1.5) all-cause and 1.0 (95% CI 0.7-1.3) cardiovascular-related deaths per day each year. Compared to the pre-Christmas/Winter period (1st-21st December), the incidence rate ratio of all-cause mortality increased to 1.22 (95% CI 1.16-1.27) and 1.17 (95% 1.11-1.22) in men and women, respectively, in the next 21 days (Christmas/New Year holiday period). All observed differences were highly significant (P<0.001). A less pronounced pattern of seasonally-linked deaths attributable to respiratory illnesses (but not cancer) was also observed.ConclusionChristmas in Central Norway is characterised by a distinctive change and increase in cardiovascular-related mortality over and above that observed between winter (more deaths) and summer (fewer deaths). This distinctive pattern contrasted with cancer-related deaths. Further research to address vulnerability to the darker consequences of winter and, more specifically Christmas, is required.


Sign in / Sign up

Export Citation Format

Share Document